Leiden

• MethMax trial Recruiting
  2023-507714-27-00 6 2024-06-20 Rheumatoid Arthritis
• Pro-RAPID Recruiting
  2023-507352-72-00 6 2024-05-24 Crohn's Disease
• A Phase 2/3 trial to investigate visualization of the ureters with nizaracianine triflutate, intravenous, in participants aged 18 years or o … Recruiting
  2023-503241-63-00 10 2024-05-21 Urinary tract imaging
• CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Recruiting
  2023-503317-29-00 5 2024-04-12 Metastatic renal cell carcinoma (mRCC)
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-1076986 in Healthy Adults. Recruiting
  2023-508305-24-00 1 2024-03-29 Movement disorders
• ​​Lomustine with or without a second round of brain radiation for the reappearance of glioblastoma Recruiting
  2023-505267-36-00 5 2024-03-15 Glioblastoma
• VulVaccin study Recruiting
  2023-506792-94-00 11 2024-03-04 Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)
• Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock f … Recruiting
  2024-510892-40-00 6 2024-02-29 Acute myocardial infarction complicated by cardiogenic shock
• Open-Label Extension of EDG-5506 in Participants with Becker Muscular Dystrophy Recruiting
  2023-506231-15-00 4 2024-02-22 Becker Muscular Dystrophy
• THC for chronic neuropathic pain Recruiting
  2022-502343-35-00 4 2024-02-20 Chronic neuropathic pain
• PREMI trial Recruiting
  2023-503220-76-01 6 2024-02-13 Unexplained recurrent miscarriages
• First in human study in healthy volunteers and participants with Parkinsons disease with and without GBA1 mutations. Recruiting
  2023-509158-68-00 1 2024-01-25 Parkinson’s disease
• A study to investigate the effect of adding cobicistat to venetoclax and azacitidine in patients with acute myeloid leukemia (AML) who are i … Recruiting
  2023-505379-61-00 4 2024-01-17 Acute Myeloid Leukaemia
• Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULC … Recruiting
  2022-502685-25-00 10 2024-01-01 The trial population will consist of patients with LAVC who require pr
• Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n … Recruiting
  2023-504637-42-01 6 2023-12-21 aortic valve stenosis
• SGM-T1: SGM-101 tumor targeted fluorescence endoscopy in rectal polyps with suspected T1 adenocarcinoma or high grade dysplasia Recruiting
  2024-510769-41-00 4 2023-12-07 Early rectal cancer
• A feasibility study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for the intraoperative detection of … Recruiting
  2024-510767-30-00 4 2023-12-04 Brain metastases
• Intensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: … Recruiting
  2023-503558-10-00 5 2023-10-13 oligometastatic pancreatic cancer
• Treatment of Menière's disease with intratympanic methylprednisolone (PREDMEN trial) Recruiting
  2023-503340-13-00 5 2023-10-05 Menière's disease
• A Phase I/II First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Anti-Tumor Activity of IMA402, a Bispecific T Cell-Engag … Recruiting
  2022-503133-54-00 7 2023-08-09 Solid Tumors
• Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma … Recruiting
  2022-501943-34-00 5 2023-06-27 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
• DEnosumab for the treatment of FIbrous Dysplasia/McCune-Albright Syndrome in adults (DeFiD): a randomized double-blind placebo-controlled tr … Recruiting
  2024-511090-30-00 11 2023-06-13 Fibrous dysplasia/McCune-Albright syndrome
• A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX- 880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaire … Recruiting
  2024-513929-23-00 10 2023-05-26 Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Seve
• Alkaline Phosphatase as treatment of Ischemia Reperfusion Injury to prevent delayed graft function or APhIRI II Recruiting
  2024-515480-66-01 4 2023-05-22 End stage kidney disease - Kidney transplantation donors receiving kid

Showing 193–216 of 459 trials